发明名称 HYDROXYFLAVONE DERIVATIVES AS TAU PROTEIN KINASE 1 INHIBITORS
摘要 A medicament for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity or a neurodegenerative disease which comprises as an active ingredient a substance selected from the group consisting of a hydroxyflavone derivative represented by formula (I) and a salt thereof, and a solvate thereof and a hydrate thereof, wherein R<1> represents hydrogen atom or hydroxyl group; R<2> represents hydrogen atom or a C1-C18 alkyl group which may have one or more C6-C14 aryl groups; and Ar represents a C6-C14 aryl group which may be substituted or an aromatic heterocyclic group which may be substituted.
申请公布号 WO0017184(A1) 申请公布日期 2000.03.30
申请号 WO1999JP05223 申请日期 1999.09.24
申请人 MITSUBISHI CHEMICAL CORPORATION;SHODA, AYA;WATANABE, KAZUTOSHI;ARITOMO, KEIICHI;JIKIHARA, TETSUO;ANDO, RYOICHI;SAITO, KEN-ICHI;HONDA, TOSHIYUKI;KAWAMOTO, RIE 发明人 SHODA, AYA;WATANABE, KAZUTOSHI;ARITOMO, KEIICHI;JIKIHARA, TETSUO;ANDO, RYOICHI;SAITO, KEN-ICHI;HONDA, TOSHIYUKI;KAWAMOTO, RIE
分类号 A61K31/352;A61K31/381;A61K31/401;A61K31/4025;A61K31/4035;A61K31/41;A61K31/4155;A61K31/4178;A61K31/422;A61K31/443;A61K31/4433;A61K31/453;A61K31/496;A61K31/501;A61K31/506;A61K31/5375;A61P7/02;A61P9/00;A61P25/16;A61P25/28;A61P43/00;C07D311/30;C07D405/04;C07D405/12;C07D407/04;C07D409/04;C07D413/04;C07D417/04 主分类号 A61K31/352
代理机构 代理人
主权项
地址